Levosulpirida [Inn-Spanish]
Brand names,
Levosulpirida [Inn-Spanish]
Analogs
Levosulpirida [Inn-Spanish]
Brand Names Mixture
Levosulpirida [Inn-Spanish]
Chemical_Formula
C15H23N3O4S
Levosulpirida [Inn-Spanish]
RX_link
No information avaliable
Levosulpirida [Inn-Spanish]
fda sheet
Levosulpirida [Inn-Spanish]
msds (material safety sheet)
Levosulpirida [Inn-Spanish]
Synthesis Reference
No information avaliable
Levosulpirida [Inn-Spanish]
Molecular Weight
341.427 g/mol
Levosulpirida [Inn-Spanish]
Melting Point
178 oC
Levosulpirida [Inn-Spanish]
H2O Solubility
2280 mg/L
Levosulpirida [Inn-Spanish]
State
Solid
Levosulpirida [Inn-Spanish]
LogP
1.337
Levosulpirida [Inn-Spanish]
Dosage Forms
Tablet
Levosulpirida [Inn-Spanish]
Indication
Sulpiride is indicated for the treatment of schizophrenia.
Levosulpirida [Inn-Spanish]
Pharmacology
Sulpiride is a substituted benzamide derivative and a selective dopamine D2 antagonist with antipsychotic and antidepressant activity. Other benzamide derivatives include metoclopramide, tiapride, and sultopride.
Levosulpirida [Inn-Spanish]
Absorption
No information avaliable
Levosulpirida [Inn-Spanish]
side effects and Toxicity
No information avaliable
Levosulpirida [Inn-Spanish]
Patient Information
No information avaliable
Levosulpirida [Inn-Spanish]
Organisms Affected
Humans and other mammals